Are there any side effects of BPC 157?

BPC 157, while showing promise in enhancing recovery, comes with significant concerns regarding potential side effects, particularly related to tumor growth:

1. Angiogenesis Risk: BPC 157 stimulates angiogenesis (the formation of new blood vessels) through the upregulation of vascular endothelial growth factor (VEGF). This mechanism is the opposite of certain cancer treatments that inhibit VEGF to reduce tumor size. Therefore, there is a potential risk that BPC 157 could inadvertently promote cancer growth or progression, especially in susceptible individuals 1.

2. Lack of Human Data: There is limited human data on the long-term effects and safety of BPC 157. Most available data come from animal studies, which, while promising, do not fully predict human responses or risks 1.

3. Monitoring Health: Users considering BPC 157 should take the minimum effective dose (typically 300 to 500 micrograms, two to three times a week) and monitor their health for any signs of cancer or tumor growth. This caution is essential given the compound's effects on vascularity and tissue recovery 1.

In summary, while BPC 157 may aid in tissue repair, the potential for serious side effects like tumor growth necessitates careful consideration and monitoring.